Clinical Trial Update: REmission in Membranous Nephropathy International Trial (REMIT) [Phase 3]

View source ↗

Summary

Phase 3 REMIT trial for primary membranous nephropathy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Membranous Nephropathy

Snippet

Sponsor: The University of Queensland | Conditions: Primary Membranous Nephropathy | Phase 3 | Status: WITHDRAWN